Journal of Developing Drugs
Open Access
ISSN: 2329-6631
+44 1478 350008
ISSN: 2329-6631
+44 1478 350008
Dr. Sisir Nandi
Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research
India
Dr. Sisir Nandi completed Ph.D. from Indian Institute of Chemical Biology (CSIR), Kolkata as a CSIR -GATE fellow and had been awarded Ph. D. in Pharmacy degree (2011) by the Jadavpur University, India. He did his Post-Doctoral research based on the prediction of new promising cycloaddition reactions: quantum chemical calculations and reactions modeling at transition state levels using different basis sets and theory under the European Union Marie Curie fellowship in Laboratory of Chemometrics, National Institute of Chemistry, Ljubljana, Slovenia, Europe. His specialization is Pharmaceutical Chemistry and research is based on the area of Pharmacoinformatics related rational drug design which includes QSAR & drug design, biological activity prediction of lead compounds, ligand-receptor interactions, virtual screening, combinatorial library design and lead-hopping. He published more than 50 original research articles and reviews in reputed international journals having high impact factor. He presented his research work in many international conferences around the world. He is the reviewers of many research articles of Medicinal Chemistry Research, Journal of Bioanalysis and Biomedicine, ASSAY and Drug Development Technologies, Combinatorial Chemistry & High Throughput Screening, Arabian Journal of Chemistry, Letters in Drug Design and Discovery, Current Medicinal Chemistry. He is Editorial advisory board of Journal of Bioanalysis and Biomedicine, Advanced Techniques in Clinical Microbiology, Journal of Computational Methods in Molecular Design; Indo American Journal of Pharmacy, EC Microbiology, Guest Editor of Current Signal Transduction Therapy and Associate Editor of Open Access Journal of Medicinal Chemistry; International Journal of Pharma Research and Health Sciences; Bioequivalence & Bioavailability International Journal (BEBA). He is having more than 12 years of research experience.
Pharmacoinformatics based QSAR & Drug Design, molecular docking, scoring function analysis, computational tools for drug discovery, design, lead optimization, virtual screening, combinatorial library design, lead-hopping, quantum chemical calculations and reactions modelling at transition state levels using different basis sets and theory.